The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Calcium supplements: bad for the heart?
Abstract
Calcium is a micronutrient widely believed to affect bone heath, though the importance of normal variations in calcium intake may have been overemphasised.1 2 Because its principal dietary source is dairy products, and because high dairy intakes are not acceptable to many older people, there has been a strong move in recent decades to increase the intake of calcium by supplements. This is most prevalent for the prevention of postmenopausal osteoporosis, but is also used in the management of serum phosphate levels in patients with renal failure. However, the safety of calcium supplements is now coming under considerable scrutiny. Their use in osteoporosis had caused concern with respect to the risk of renal calculi, which is increased by about 20%.3 There has also been a longstanding awareness that they cause gastrointestinal symptoms, particularly constipation, but it is more alarming to find that they double the risk of admission to hospital with an acute abdominal condition.4 The concern that most threatens their continuing use, however, is their potential risk to cardiovascular health. Although there is trial evidence that calcium supplements can improve high-density lipoprotein/low-density lipoprotein ratios by almost 20%, and reduce both systolic and diastolic blood pressure by a few mm Hg, this does not appear to translate into fewer cardiovascular events. This concern first surfaced in nephrology practice with evidence that calcium supplements exacerbated vascular calcification and contributed to the very high cardiovascular mortality experienced by those patients. Randomised trials in pre-dialysis patients have demonstrated acceleration of coronary artery calcification,5 and some trials have shown increased cardiovascular mortality in patients randomised to calcium.6 More recently, the focus of concern about cardiovascular …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intakes in excess of 1200 to 1500 mg/day may increase the risk of developing kidney stones, cardiovascular disease, and stroke.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [32]
Citations
Cites
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883 · cited 1×
“Their use in osteoporosis had caused concern with respect to the risk of renal calculi, which is increased by about 20%.(3) There has also been a longstanding awareness that they cause gastrointestinal symptoms, particularly constipation, but it is more alarming to find that they double the risk of admission to hospit…”
BackgroundTang, B. M., Eslick, G. D., Nowson, C., Smith, C., & Bensoussan, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61342-7 · Cited by 1,248
Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010) · BMJ · doi:10.1136/bmj.c3691 · Cited by 1,099 · cited 2×
“The Bolland meta-analysis of calcium monotherapy demonstrated that the treatment of 1000 older adults with calcium for 5 years resulted in 14 more myocardial infarctions, 10 more strokes and 13 more deaths, to be balanced against 26 fewer fractures.(9) Similar analyses in younger cohorts also show the net balance to b…”
BackgroundMethodSelf-citationBolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851
Self-citationBlock, G. A., Raggi, P., Bellasi, A., Kooienga, L., & Spiegel, D. M. (2007) · Kidney International · doi:10.1038/sj.ki.5002059 · Cited by 796
Curhan, G. C., Willett, W. C., Speizer, F. E., Spiegelman, D., & Stampfer, M. J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-7-199704010-00001 · Cited by 753 · cited 1×
“A parallel situation exists for renal calculi, where supplements increase the risk, but dietary calcium may be protective.(17) How can these differences be explained? There is a substantial observational literature demonstrating that high-normal serum calcium levels are associated with an increased risk of vascular ca…”
BackgroundBolland, M. J., Barber, P. A., Doughty, R. N., Mason, B., Horne, A., Ames, R., Gamble, G. D., Grey, A., & Reid, I. R. (2008) · BMJ · doi:10.1136/bmj.39440.525752.be · Cited by 691 · cited 1×
“A trial of 1471 healthy postmenopausal women who were randomised to receive calcium 1 g/ day or placebo over 5 years, showed increases of about 40% in cardiovascular event rates in the former group.(7) Myocardial infarction and stroke were prespecified secondary end points in this trial, and the events were adjudicate…”
MethodSelf-citationCalcium/Vitamin D Supplementation and Cardiovascular Events
Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Heckbert, S. R., Johnson, K. C., Manson, J. E., Sidney, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.673491 · Cited by 662
Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events
Wang, L., Manson, J. E., Song, Y., & Sesso, H. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-5-201003020-00010 · Cited by 518 · cited 1×
“In a meta-analysis of published cardiovascular events in three clinical trials involving 3861 subjects, Wang et al reported a statistically nonsignificant 14% increase in the risk of a mixture of cardiovascular events with calcium supplements, concluding that these supplements had minimal effects on cardiovascular ris…”
MethodRusso, D., Miranda, I., Ruocco, C., Battaglia, Y., Buonanno, E., Manzi, S., Russo, L., Scafarto, A., & Andreucci, V. E. (2007) · Kidney International · doi:10.1038/sj.ki.5002518 · Cited by 334
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
“Increasing calcium intake beyond the recommended levels has not been shown to be useful and may be harmful (140-144).”
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.gl · Cited by 478
Metadata
- Authors
- Reid, I. R., & Bolland, M. J.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Reid, Ian R
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2012-05-23
- Volume
- 98
- Issue
- 12
- Pages
- 895-896
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2124356073
- Cited by
- 39
- References
- 22
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 6 · 2013: 10 · 2012: 5
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Heart (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- calcium supplements, cardiovascular risk, vascular calcification, coronary artery calcification, cardiovascular mortality, postmenopausal osteoporosis, renal failure, hypercalcemia, acute abdomen, kidney stones, blood pressure, HDL/LDL ratio
- MeSH terms
- Calcinosis, Calcium, Calcium, Dietary, Coronary Artery Disease, Coronary Vessels, Female, Humans, Male, New Zealand, Osteoporosis, Prognosis, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcium supplements: bad for the heart? https://app.cochat.ai/papers/10.1136/heartjnl-2012-301904
- The paper
- Reid, I. R., & Bolland, M. J. (2012). Calcium supplements: bad for the heart? Heart. https://doi.org/10.1136/heartjnl-2012-301904
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.